Familial Amyloidosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-06-04
Clinical Trial Update: Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
A clinical trial is recruiting to study subclinical transthyretin cardiac amyloidosis in individuals carrying the V122I TTR mutation.